Literature DB >> 22580214

The ancestry of the HLA-DRB1*15 allele predisposes the Mexican mestizo to the development of aplastic anemia.

Javier Fernández-Torres1, Denhi Flores-Jiménez, Antonio Arroyo-Pérez, Julio Granados, Alberto López-Reyes.   

Abstract

UNLABELLED: Aplastic anemia (AA) is a hematological disorder characterized by pancytopenia in peripheral blood and hypoplasia in the bone marrow; the majority of cases have no known etiology, but it is thought that genetic and environmental factors can be involved in its pathogenesis. From the genetic viewpoint, it has been reported a significant increase frequency of the human leukocyte antigen HLA-DRB1(∗)15 in patients with AA as compared to ethnically matched healthy controls, this is true in different populations worldwide, which would suggests that this allele participates in the immune regulation of the disease.
OBJECTIVE: To determine gene frequencies of HLA-DRB1 alleles in Mexican mestizo patients with AA.
METHODS: We analyzed and compared the HLA-DRB1 alleles in 36 Mexican mestizo patients (female gender, n=13; male gender, n=23) with AA to those present in 201 umbilical cord blood (UCB) samples as a control group, this was done by means of the polymerase chain reaction-single specific primer (PCR-SSP) technique.
RESULTS: Analysis of gene frequencies of HLA-DRB1(∗) alleles exhibits a significant increase of HLA-DRB1(∗)15 allele in the group of patients with AA as compared to those present in the control group (15.27% vs. 2.23%, respectively; p=1×10(-5); odds ratio [OR]=9.3; 95% confidence interval [95% CI]=3.2-27.8).
CONCLUSIONS: Our results showed a positive association of the DRB1(∗)15 allele in Mexican patients with aplastic anemia, which coincides with that reported internationally. In addition, we think that this allele was introduced to the Mexican population structure inherited from European ancestry.
Copyright © 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580214     DOI: 10.1016/j.humimm.2012.04.012

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  4 in total

1.  Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications.

Authors:  Daria V Babushok; Jamie L Duke; Hongbo M Xie; Natasha Stanley; Jamie Atienza; Nieves Perdigones; Peter Nicholas; Deborah Ferriola; Yimei Li; Hugh Huang; Wenda Ye; Jennifer J D Morrissette; Jane Kearns; David L Porter; Gregory M Podsakoff; Laurence C Eisenlohr; Jaclyn A Biegel; Stella T Chou; Dimitrios S Monos; Monica Bessler; Timothy S Olson
Journal:  Blood Adv       Date:  2017-10-10

Review 2.  Acquired Aplastic Anemia as a Clonal Disorder of Hematopoietic Stem Cells.

Authors:  Katarzyna Brzeźniakiewicz-Janus; Joanna Rupa-Matysek; Lidia Gil
Journal:  Stem Cell Rev Rep       Date:  2020-06       Impact factor: 5.739

Review 3.  Genetic associations in acquired immune-mediated bone marrow failure syndromes: insights in aplastic anemia and chronic idiopathic neutropenia.

Authors:  Irene Mavroudi; Helen A Papadaki
Journal:  Clin Dev Immunol       Date:  2012-08-26

4.  Association of Human Leukocyte Antigen DRB1*15 and DRB1*15:01 Polymorphisms with Response to Immunosuppressive Therapy in Patients with Aplastic Anemia: A Meta-Analysis.

Authors:  Shan Liu; Qing Li; Ying Zhang; Qiushuang Li; Baodong Ye; Dijiong Wu; Li Wu; Hanti Lu; Conghua Ji
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.